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G- banding - Courtesy Melanie Zenger and Claudia Haferlach. 
 
Clinics and pathology 
Disease 
Diffuse large cell lymphoma. 
Epidemiology 
Only one case to date, a 64 year old male patient. 
Evolution 
Complete remission was obtained. 
Cytogenetics 
Cytogenetics, morphological 
Sole anomaly within the subclone 





DNA / RNA 
Spans on 25 kb; 11 exons. 
Protein 
Sequence-specific DNA binding transcriptional 
repressor. 
IL21R (or IL21R-alpha) 
Location: 16p11 
DNA / RNA 
Spans on 48 kb; 10 exons. 
Protein 
IL21R is, in fact, an heterodimer made of IL21R-alpha, 
and the common gamma chain (CD132); IL21Ra is the 
private receptor of IL21; IL21/IL21R, selectively 
expressed in lymphoid cells, activates the JAK/STAT 
transcription signaling pathway; IL21/IL21R plays a 
role in proliferation, differenciation of T cells, B cells, 
natural killers (NK) cells, and dendritic cells.; promotes 
and inhibit immune responses. 
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The IL21R promoter region replaces the regulatory 
sequences of BCL6; the chimeric mRNA consists of 
the 2 non coding exons 1a/1b of IL21R and the coding 
exons of BCL6. 
Fusion protein 
Oncogenesis 
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